Toxicity and Efficacy Outcomes of Teclistamab in Patients with Relapsed-Refractory Multiple Myeloma (RRMM) above the Age of 70 Years: A Multicenter StudyDanai Dima,Aishwarya Sannareddy,Nausheen Ahmed,James A. Davis,Hira Shaikh,Zahra Mahmoudjafari,Marissa Duco,Jack Khouri,Gurbakhash Kaur,Jonathan Lochner,Faiz Anwar,Aimaz Afrough,Jason Valent,Hamza Hashmi,Al-Ola AbdallahBLOOD(2023)引用 5|浏览14关键词Tumor RegressionAI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要